Clinical development plan: sulindac sulfone.
D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D017277:Drug Approval; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000188:drug therapy / Q000517:prevention & control*; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000517:prevention & control; D051381:Rats; D012107:Research Design; D013467:Sulindac / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use
D016588:Anticarcinogenic Agents; D013467:Sulindac; C025463:sulindac sulfone